← Back to catalogue

Lyphochek

FDA UDI

Class I (US FDA UDI)

by Bio-Rad Laboratories

Identity

Trade Name
Lyphochek FDA UDI
Generic Name
Multiple tissue-associated protein/tumour marker IVD, control FDA UDI
Device Name
Lyphochek Tumor Marker Plus Control Level 3 (A human based assayed tumor marker control.) FDA UDI
Model / Reference
369 FDA UDI
Description
Lyphochek Tumor Marker Plus Control Level 3 (A human based assayed tumor marker control.) FDA UDI

Identifiers

Catalog Number
369 FDA UDI
Primary DI / UDI-DI
00847661001430 FDA UDI
510(k) Number
K082036 FDA UDI
FDA Product Code
JJY FDA UDI
GMDN Term
Multiple tissue-associated protein/tumour marker IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple tissue-associated protein/tumour marker IVD, control

Lyphochek by Bio-Rad Laboratories — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple tissue-associated protein/tumour marker IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 9512e917-06e2-4323-8490-75e1c8018758 37 fields · synced May 30, 2026